Status:

COMPLETED

Effects of a Nutraceutic Compound on Cognitive Impairment

Lead Sponsor:

Federico II University

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

40+ years

Phase:

PHASE4

Brief Summary

The study is designed to evaluate the effects of choline bitartrate on cognitive impairment in frailty patients. The study will analyze the impact of 4 weeks treatment randomized with a nutraceutical...

Detailed Description

The patients and controls will be recruited at the Hypertension research center of Federico II university hospital. The overall duration of the study will be 4 weeks for each participant. Blood press...

Eligibility Criteria

Inclusion

  • Mild cognitive impairment

Exclusion

  • Ictus Atrial fibrillation Kidney diseases Cancer

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2023

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT06200883

Start Date

September 1 2022

End Date

November 1 2023

Last Update

January 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ambulatorio Ipertensione e Unità Coronarica Federico II University

Napoli, Italy, 80131